anti-PSA mAbs (University of California/AIT)

N/A

Report date: 2025/03/14 20:00:48

Base Information

Drug Nameanti-PSA mAbs (University of California/AIT)
Drug Alias Nameanti-PSA IgG1anti-PSA monoclonal antibodies (University of California/Advanced Immune Therapeutics)anti-PSA IgG3
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Chimeric monoclonal antibody
Mechanisms of ActionProstate-specific antigen inhibitors
TargetsProstate-specific antigen
Therapy Area/IndicationsProstatic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAdvanced Immune Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAdvanced Immune Therapeutics IncUniversity Of California
Active IndicationsN/A
Inactive IndicationsProstatic Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A